A migrant worker receives a jab while being injected with one dose Sputnik Light vaccine against COVID-19 in a vaccination center at a city market in Moscow Russia. Reuters/File

The Food and Drug Administration (FDA) in the Philippines on Monday approved the emergency use authorization (EUA) of a single dose Russian made Sputnik Light COVID -19 vaccine.

FDA chief Eric Domingo said Sputnik Light is the ninth COVID-19 vaccine approved by the Philippines, along with vaccines from Pfizer, Moderna, Johnson & Johnson, China’s Sinovac and Sinopharm, and Russia’s 2-dose Sputnik V.

Sputnik Light demonstrated 93.5 percent efficacy among 320,000 in Paraguay, with data taken from the South American country’s vaccination campaign as of July 30, the Russian Direct Investment Fund (RDIF) said last week.

Developed by Moscow’s Gamaleya Institute, Sputnik Light had shown 79.4 percent efficacy when it was first authorized for use in May.

“The use of the single-component vaccine Sputnik Light allows the Paraguayan authorities to shorten vaccination periods for the population and speed up the formation of collective immunity,” RDIF head Kirill Dmitriev said in a statement.

Mongolia and Kazakhstan have approved Sputnik Light, developed by Russia’s Gamaleya Institute.

Meanwhile, vaccine czar Carlito Galvez Jr. said with the approval of the EUA they can now follow up its order of 10 million doze.